Lexaria Bioscience Corp logo

Lexaria Bioscience Corp

NAS:LEXX (Canada)  
$ 2.21 +0.01 (+0.45%) 11:09 PM EST
At Loss
P/B:
4.31
Market Cap:
$ 38.40M
Enterprise V:
$ 32.12M
Volume:
35.04K
Avg Vol (2M):
169.29K
Trade In:
Volume:
35.04K
At Loss
Avg Vol (2M):
169.29K

Business Description

Description
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
Name Current Vs Industry Vs History
Cash-To-Debt 47.85
Equity-to-Asset 0.91
Debt-to-Equity 0.02
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.73
Distress
Grey
Safe
Beneish M-Score -2.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 48.48
9-Day RSI 47.09
14-Day RSI 46.47
6-1 Month Momentum % -21.13
12-1 Month Momentum % 62.02

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.19
Quick Ratio 7.19
Cash Ratio 5.97
Days Sales Outstanding 38.55
Days Payable 22542.4

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -40.3
Shareholder Yield % -11.07

Financials (Next Earnings Date:2025-01-10 Est.)

LEXX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LEXX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Lexaria Bioscience Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.464
EPS (TTM) ($) -0.47
Beta 0.81
Volatility % 155.92
14-Day RSI 46.47
14-Day ATR ($) 0.195801
20-Day SMA ($) 2.2735
12-1 Month Momentum % 62.02
52-Week Range ($) 1.2 - 6.85
Shares Outstanding (Mil) 17.45

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Lexaria Bioscience Corp Filings

Filing Date Document Date Form
No Filing Data

Lexaria Bioscience Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Lexaria Bioscience Corp Frequently Asked Questions

What is Lexaria Bioscience Corp(LEXX)'s stock price today?
The current price of LEXX is $2.21. The 52 week high of LEXX is $6.85 and 52 week low is $1.20.
When is next earnings date of Lexaria Bioscience Corp(LEXX)?
The next earnings date of Lexaria Bioscience Corp(LEXX) is 2025-01-10 Est..
Does Lexaria Bioscience Corp(LEXX) pay dividends? If so, how much?
Lexaria Bioscience Corp(LEXX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1